Levotuss Tosse

Levodropropizine, the active ingredient in Levotuss Tosse, is a peripheral antitussive presented as an oral formulation for systemic use. It is used to suppress cough reflexes in patients with acute or chronic cough, particularly when the cough is non‑productive and causes discomfort. Levotuss Tosse is marketed in the European Union and is supplied without a specified strength or dosage form.

GNH USA supplies Levotuss Tosse as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Levodropropizine acts on the peripheral cough pathway to alleviate coughing associated with respiratory irritation.

- Acute cough: reduces the frequency and intensity of coughing episodes during short‑term respiratory infections. - Chronic cough: helps control persistent cough when underlying causes have been evaluated. - Non‑productive cough: eases irritation‑driven cough without sputum production, improving patient comfort.

Levodropropizine is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Dry mouth: mild reduction in salivary flow. - Nausea: occasional feeling of stomach upset. - Dizziness: transient light‑headedness. - Headache: mild to moderate pain. - Gastrointestinal discomfort: mild abdominal pain or dyspepsia.

Serious or Rare Side Effects: - Allergic reactions: rash, pruritus, or angioedema. - Hepatic dysfunction: elevated liver enzymes. - Severe dizziness or vertigo. - Persistent vomiting. - Anaphylaxis: rare but life‑threatening hypersensitivity.

When considering levodropropizine therapy, several safety measures should be observed.

- Pregnancy: consult a healthcare professional before use; safety data are limited. - Breastfeeding: discuss potential risks with a physician, as drug may pass into milk. - Hepatic impairment: use with caution; monitor liver function if indicated. - Concomitant CNS depressants: avoid unnecessary combination as additive effects are unlikely but caution is advised. - Pediatric use: dosage and safety must be determined by a pediatrician. - Store at ambient temperature: keep below 25 °C, retain in original packaging, protect from moisture and direct sunlight.

Levodropropizine may interact with other medicines; awareness of potential interactions helps ensure safe use.

Major Interactions (Avoid): - CYP450 inhibitors: may increase plasma levels, raising risk of adverse effects. - Strong anticholinergic agents: could exacerbate dry mouth.

Moderate Interactions (Monitor Closely): - Other antitussives: additive cough suppression may lead to excessive suppression. - Sedatives or hypnotics: monitor for enhanced dizziness. - NSAIDs: watch for gastrointestinal discomfort when combined.